Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus

Published:2024-09 Issue: Volume: Page:107432
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

Manzi Giovanna,Benza Raymond L.,Argiento Paola,Casu Gavino,Corda Marco,Correale Michele,D'Alto Michele,Galgano Giuseppe,Garascia Andrea,Ghio Stefano,Gomberg-Maitland Mardi,Mulé Massimiliano,Paciocco Giuseppe,Papa Silvia,Prati Daniele,Preston Ioana R.,Raineri Claudia,Romeo Emanuele,Scelsi Laura,Stolfo Davide,Vitulo Patrizio,White R. James,Badagliacca Roberto,Vizza Carmine Dario

Publisher

Elsevier BV

Reference73 articles.

1. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension;Humbert;Eur. Respir. J.,2022

2. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

3. Development and validation of an abridged version of the REVEAL 2.0 risk score calculator, REVEAL lite 2, for use in patients with pulmonary arterial hypertension;Benza;Chest,2021

4. COMPERA 2.0: a refined 4-strata risk assessment model for pulmonary arterial hypertension;Hoeper;Eur. Respir. J.,2021

5. Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension;Badagliacca;J. Heart Lung Transplant.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP